CLDN1 and neoplasm: Gene expression profiling demonstrated that none of these HCV-entry factors, i.e., CLDN1, OCLN, SR-B1 and CD81, were differentially expressed within the tumor compared to the surrounding nontumorous tissue, indicating that the abnormal distribution of CLDN1 and OCLN occurs at the post-transcriptional level.